Zacks Investment Research upgraded shares of Exponent (NASDAQ:EXPO – Get Rating) from a hold rating to a buy rating in a report published on Monday, Zacks.com reports. The firm currently has $107.00 price target on the business services provider’s stock.
According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “
A number of other brokerages have also recently commented on EXPO. Truist Financial increased their price target on Exponent from $115.00 to $120.00 and gave the company a buy rating in a research note on Tuesday, April 5th. StockNews.com initiated coverage on Exponent in a research report on Thursday, March 31st. They set a hold rating for the company.
Exponent (NASDAQ:EXPO – Get Rating) last announced its quarterly earnings results on Thursday, April 28th. The business services provider reported $0.56 EPS for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.04. Exponent had a return on equity of 24.76% and a net margin of 20.90%. The company had revenue of $117.90 million during the quarter, compared to analysts’ expectations of $115.50 million. During the same period in the prior year, the company earned $0.58 EPS. Exponent’s revenue was up 7.6% compared to the same quarter last year. On average, research analysts anticipate that Exponent will post 1.8 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, June 24th. Investors of record on Friday, June 10th will be given a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 1.02%. The ex-dividend date is Thursday, June 9th. Exponent’s dividend payout ratio is currently 51.06%.
In related news, Director George H. Brown bought 2,000 shares of the stock in a transaction that occurred on Tuesday, February 8th. The stock was acquired at an average cost of $85.18 per share, with a total value of $170,360.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.80% of the stock is owned by company insiders.
Hedge funds have recently bought and sold shares of the company. JFS Wealth Advisors LLC bought a new position in shares of Exponent in the 4th quarter worth about $37,000. Confluence Wealth Services Inc. bought a new position in shares of Exponent in the 4th quarter worth about $38,000. Allworth Financial LP raised its position in shares of Exponent by 120.1% in the 1st quarter. Allworth Financial LP now owns 328 shares of the business services provider’s stock worth $35,000 after acquiring an additional 179 shares in the last quarter. Fieldpoint Private Securities LLC raised its position in shares of Exponent by 34.4% in the 1st quarter. Fieldpoint Private Securities LLC now owns 465 shares of the business services provider’s stock worth $50,000 after acquiring an additional 119 shares in the last quarter. Finally, Rockefeller Capital Management L.P. raised its position in shares of Exponent by 96.1% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 604 shares of the business services provider’s stock worth $68,000 after acquiring an additional 296 shares in the last quarter. 89.82% of the stock is owned by hedge funds and other institutional investors.
Exponent Company Profile (Get Rating)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
- Get a free copy of the StockNews.com research report on Exponent (EXPO)
- MarketBeat Podcast: Investing In Innovation, Robotics, AI and Healthcare
- It’s Time to Book an Appointment for Teladoc Stock
- Saia Growth Accelerates But It May Not Matter
- GitLab Stock is Trying to Put in a Bottom Here
- onsemi Is A Deep-Value In The Chip Sector
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.